Rehmannioside A

CAS No. 81720-05-0

Rehmannioside A( —— )

Catalog No. M19140 CAS No. 81720-05-0

Rehmannioside A is an iridoid glucoside extracted from traditional Chinese medicine Rehmannia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 171 In Stock
10MG 250 In Stock
25MG 422 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rehmannioside A
  • Note
    Research use only, not for human use.
  • Brief Description
    Rehmannioside A is an iridoid glucoside extracted from traditional Chinese medicine Rehmannia.
  • Description
    Rehmannioside A is an iridoid glucoside extracted from traditional Chinese medicine Rehmannia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    81720-05-0
  • Formula Weight
    524.5
  • Molecular Formula
    C21H32O15
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CO[C@H]([C@H]2[C@@H]1[C@@H]([C@H]1[C@@]2(O1)CO)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Liu C, et al. Rehmanniae Radix in osteoporosis: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics and pharmacology. J Ethnopharmacol. 2017 Feb 23;198:351-362.
molnova catalog
related products
  • Golimumab

    Golimumab (CNTO-148) is a potent humanized anti-TNFα IgG1κ monoclonal antibody with anti-inflammatory and anticancer activity.

  • GSK3145095

    GSK3145095 is an orally active inhibitor of RIPK1 with IC50 of 5 nM, with potential immunomodulatory activities and antineoplastic.

  • Ozoralizumab

    Ozoralizumab (ATN-103) is a humanized anti-TNFα antibody and a novel TNFα inhibitor.Ozoralizumab binds human serum albumin and can be used to study rheumatoid arthritis.